PUBLISHER: The Business Research Company | PRODUCT CODE: 1927061
PUBLISHER: The Business Research Company | PRODUCT CODE: 1927061
Organ preservation solutions are specially formulated solutions designed for the preservation of organs during transplantation or storage. These solutions play a crucial role in safeguarding organs from potential damage during the transplantation process and extending the period for which organs can be stored outside of the body. Organ preservation solutions are formulated with specific agents that aim to mitigate ischemia-reperfusion injury (IRI) by employing targeted mechanisms of action.
There are several main types of organ preservation solutions, including Viaspan, Custodiol-HTK (Histidine-Tryptophan-Ketoglutarate), Renograf, Hypothermosol, Perfadex, Lifor, HBS (Hyperosmotic Blood Substitute) Solution, siRNA (Small Interfering RNA) Transplant Solutions, and others. Viaspan, for example, is utilized for the cold storage preservation of solid organs such as the liver, pancreas, and kidneys. It plays a crucial role in maintaining organ viability during transportation and before transplantation. These solutions are employed in preserving various organs, including kidneys, liver, lungs, hearts, and others, utilizing techniques such as static cold storage (SCS) and hypothermic machine perfusion. These preservation techniques are essential for ensuring the successful transplantation of organs and improving overall patient outcomes.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Tariffs are impacting the organ preservation solution market by increasing costs of imported pharmaceutical ingredients, sterile packaging materials, cold-chain equipment, and perfusion system components. Transplant centers in North America and Europe are most affected due to reliance on imported solutions, while Asia-Pacific faces higher costs for advanced preservation technologies. These tariffs are increasing procurement costs for healthcare providers. However, they are also encouraging local manufacturing, regional supply chain development, and innovation in cost-effective preservation solutions.
The organ preservation solution market research report is one of a series of new reports from The Business Research Company that provides organ preservation solution market statistics, including organ preservation solution industry global market size, regional shares, competitors with a organ preservation solution market share, detailed organ preservation solution market segments, market trends and opportunities, and any further data you may need to thrive in the organ preservation solution industry. This organ preservation solution market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The organ preservation solution market size has grown strongly in recent years. It will grow from $0.31 billion in 2025 to $0.33 billion in 2026 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to growth of organ transplantation procedures, expansion of transplant infrastructure, increasing availability of preservation solutions, adoption of cold storage techniques, advancements in medical preservation chemistry.
The organ preservation solution market size is expected to see strong growth in the next few years. It will grow to $0.43 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to increasing organ transplant demand, rising adoption of advanced preservation technologies, expansion of machine perfusion systems, growing focus on transplant success rates, innovation in organ protection formulations. Major trends in the forecast period include advancements in ischemia-reperfusion injury mitigation, rising adoption of machine perfusion techniques, growing use of multi-organ preservation solutions, expansion of transplant storage durations, enhanced focus on organ viability.
The increase in healthcare spending is driving the growth of the organ preservation solution market. Healthcare spending refers to the total financial resources allocated to the healthcare sector within a specific region, country, or organization. Organ preservation solutions are critical in optimizing the success of organ transplantation procedures, as they preserve organs during transportation and storage to ensure viability. Investment in these solutions contributes to improved transplant outcomes, reducing complications and associated healthcare costs. For instance, in November 2023, according to the Canadian Institute for Health Information, total health spending in Canada was projected to reach $344 billion, or $8,740 per person. This represents a 2.8% increase compared to the 1.5% growth in 2022, indicating a notable rebound in healthcare investment. Therefore, the increase in healthcare spending is propelling the growth of the organ preservation solution market going forward.
Product innovation is a significant trend gaining traction in the organ preservation solution market. Leading companies in this sector are concentrating on developing cutting-edge products to enhance their position and secure a competitive edge. For example, in June 2024, Paragonix Technologies, a US-based firm specializing in organ preservation technology, introduced the PancreasPak Organ Preservation System. This device is the first to receive FDA clearance specifically designed to protect and monitor donor pancreases during transportation, underscoring its crucial role in organ transplantation. The system creates a controlled environment that maintains the pancreas at an optimal thermal range of 4-8°C, which is vital for preserving the organ's viability and functionality during transport, which can last up to 21 hours. The PancreasPak is also equipped with digital monitoring capabilities that continuously track the temperature and surrounding conditions of the pancreas. This real-time data facilitates immediate action in response to any deviations from optimal conditions, thereby enhancing organ preservation.
In September 2024, Getinge, a Sweden-based medical technology firm, acquired Paragonix Technologies for $253 million. This acquisition enables Getinge to enter the fast-growing organ preservation and transportation market, which is witnessing substantial growth driven by rising transplant volumes and technological advancements. Paragonix Technologies is a US-based biotechnology company specializing in organ preservation solutions.
Major companies operating in the organ preservation solution market are Bridge to Life, XVIVO Perfusion, Organ Recovery Systems, Dr. Franz Kohler Chemie, BioLife Solutions, Essential Pharmaceuticals, Preservation Solutions, KPS Life, Hibernicor, Advanced Organ Biosciences, Paragonix Technologies, TransMedics, OrganOx, Organ Assist, XVIVO Lung Perfusion, Cell and Tissue Systems, Sustained Medical, Organ Preservation Alliance, Lifeline Scientific, Arthrex
North America was the largest region in the organ preservation solution market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the organ preservation solution market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the organ preservation solution market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The organ preservation solution market consists of sales of the histidine-tryptophan-ketoglutarate solution and hypertonic citrate adenine solution. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Organ Preservation Solution Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses organ preservation solution market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for organ preservation solution ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The organ preservation solution market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.